MSB 3.21% $1.13 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-722

  1. 701 Posts.
    lightbulb Created with Sketch. 108
    Very wise indeed, but us holders could make 500% ... or lose 90% .
    It is more exciting, and it almost makes sense, statistically.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.